Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients

[1]  T. Sigmundsson,et al.  Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study , 1996, Psychopharmacology.

[2]  B. Winblad,et al.  Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature , 2005, Journal of Neural Transmission.

[3]  J. Lieberman,et al.  Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. , 2004, The Journal of clinical psychiatry.

[4]  B. Kinon,et al.  Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials , 2003, Psychoneuroendocrinology.

[5]  B. Kinon,et al.  Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone 1 1 This work was sponsored by Eli Lilly and Company. , 2003, Psychoneuroendocrinology.

[6]  M. F. Denisov.  Re: Prolactin levels and adverse events in patients treated with risperidone. , 2002, Journal of clinical psychopharmacology.

[7]  S. Kapur,et al.  Elevation of prolactin levels by atypical antipsychotics. , 2002, The American journal of psychiatry.

[8]  J. Lieberman,et al.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. , 2001, The American journal of psychiatry.

[9]  S. Kapur,et al.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.

[10]  A. Luciano,et al.  Clinical presentation of hyperprolactinemia. , 1999, The Journal of reproductive medicine.

[11]  S. Kapur,et al.  Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. , 1999, The American journal of psychiatry.

[12]  J. Rapoport,et al.  Elevated prolactin in pediatric patients on typical and atypical antipsychotics. , 1999, Journal of child and adolescent psychopharmacology.

[13]  K. Någren,et al.  Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. , 1998, The American journal of psychiatry.

[14]  G. Tollefson,et al.  The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations , 1997, Schizophrenia Research.

[15]  D. Charney,et al.  Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT , 1995 .

[16]  P. Marken,et al.  Management of psychotropic-induced hyperprolactinemia. , 1992, Clinical pharmacy.

[17]  J. Peedicayil,et al.  A STUDY OF SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: COMPARISON OF MALES AND FEMALES , 1992, Clinical and experimental pharmacology & physiology.

[18]  R. Rubin,et al.  Haloperidol and prolactin concentrations in Asians and Caucasians. , 1988, Journal of clinical psychopharmacology.

[19]  G. Sedvall,et al.  Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients , 1977, Acta psychiatrica Scandinavica.